| Authors: |
Juraska M; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. Electronic address: mjuraska@fredhutch.org., Early AM; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Li L; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Schaffner SF; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Lievens M; GSK, Wavre, Belgium., Khorgade A; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Simpkins B; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Hejazi NS; Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA, USA., Benkeser D; Emory University Rollins School of Public Health, Department of Biostatistics and Bioinformatic, Atlanta, GA, USA., Wang Q; Department of Statistics, University of Washington, Seattle, WA, USA., Mercer LD; PATH, Seattle, WA, USA., Adjei S; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Agbenyega T; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Anderson S; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Ansong D; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Bii DK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Buabeng PBY; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., English S; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Fitzgerald N; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Grimsby J; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Kariuki SK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Otieno K; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Roman F; GSK, Wavre, Belgium., Samuels AM; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Westercamp N; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Ockenhouse CF; PATH, Seattle, WA, USA., Ofori-Anyinam O; GSK, Wavre, Belgium., Lee CK; PATH, Seattle, WA, USA., MacInnis BL; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA., Wirth DF; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA., Gilbert PB; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA; Department of Biostatistics, University of Washington, Hans Rosling Center for Population Health, Seattle, WA, USA., Neafsey DE; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA. Electronic address: neafsey@hsph.harvard.edu. |
